Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
A Single-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of Prednisolone Sodium Phosphate Ophthalmic Solution, 1% Compared to Placebo in a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated:  12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model
A Single-Center, Double-Masked, Randomized, Placebo-Controlled Evaluation of Prednisolone Sodium Phosphate Ophthalmic Solution, 1% Compared to Placebo in a Modified Conjunctival Allergen Challenge (CAC) Model
Status: Enrolling
Updated: 12/31/1969
Andover Eye Associates
mi
from
Andover, MA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Artesia, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Artesia, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Danbury, CT
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Danbury, CT
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Fort Myers, FL
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Hoffman Estates, IL
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Indianapolis, IN
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Lexington, KY
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Des Peres, MO
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Des Peres, MO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
New York, NY
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Cleveland, OH
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Philadelphia, PA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Houston, TX
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Norfolk, VA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Hemet, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Hemet, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Lancaster, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Lancaster, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Mission Hills, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Mission Hills, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Montebello, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Montebello, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Newport Beach, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Petaluma, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Petaluma, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational SIte
mi
from
Rancho Cordova, CA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational SIte
mi
from
Rancho Cordova, CA
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
New Albany, IN
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
New Albany, IN
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Saint Paul, MN
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Chesterfield, MO
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Independence, MO
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Independence, MO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Kansas City, MO
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Washington, MO
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Washington, MO
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
Wantagh, NY
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
Wantagh, NY
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
League City, TX
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
League City, TX
Click here to add this to my saved trials
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated:  12/31/1969
OPUS-2 Investigational Site
mi
from
San Antonio, TX
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
Status: Enrolling
Updated: 12/31/1969
OPUS-2 Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated:  12/31/1969
Palmetto Retina Center
mi
from
West Columbia, SC
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Palmetto Retina Center
mi
from
West Columbia, SC
Click here to add this to my saved trials
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston/The Medical Center
mi
from
Houston, TX
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston/The Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston/Katy office
mi
from
Katy, TX
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston/Katy office
mi
from
Katy, TX
Click here to add this to my saved trials
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated:  12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
A Phase IIIb, Multicenter, Randomized, Controlled Study of the Safety, Tolerability and Efficacy of IVT 0.5mg Ranibizumab Monthly Compared to a Treat & Extend Protocol in Patients With Wet Age-related Macular Degeneration (T-REX)
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Houston
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated:  12/31/1969
Bausch & Lomb
mi
from
Rochester, NY
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension.
Status: Enrolling
Updated: 12/31/1969
Bausch & Lomb
mi
from
Rochester, NY
Click here to add this to my saved trials
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Bausch & Lomb
mi
from
Rochester, NY
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
A Randomized, Multicenter, Double-Masked, Parallel-Group Study Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Bausch & Lomb
mi
from
Rochester, NY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Colorado Retina Associates
mi
from
Golden, CO
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Colorado Retina Associates
mi
from
Golden, CO
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Eldorado Retina Associates
mi
from
Louisville, CO
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Eldorado Retina Associates
mi
from
Louisville, CO
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
New England Retina Associates
mi
from
Hamden, CT
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
New England Retina Associates
mi
from
Hamden, CT
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Medical Center Eye Institute / Gulf Region Clinical Research Institute
mi
from
Pensacola, FL
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Medical Center Eye Institute / Gulf Region Clinical Research Institute
mi
from
Pensacola, FL
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Gailey Eye Clinic
mi
from
Bloomington, IL
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Gailey Eye Clinic
mi
from
Bloomington, IL
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Kentucky
mi
from
Lexington, KY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
New England Eye Center / Tufts Medical Center
mi
from
Boston, MA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
New England Eye Center / Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Vitreo-Retinal Associates, PC
mi
from
Worcester, MA
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Vitreo-Retinal Associates, PC
mi
from
Worcester, MA
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Specialists of Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
The Retina Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Lifelong Vision Foundation
mi
from
Chesterfield, MO
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Lifelong Vision Foundation
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
New Jersey Retina
mi
from
Toms River, NJ
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
New Jersey Retina
mi
from
Toms River, NJ
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
MaculaCare
mi
from
New York, NY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
MaculaCare
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)
A Randomized, Double Blind, Placebo Controlled Study Evaluating ORACEA® in Subjects With Geographic Atrophy Secondary to Non-Exudative Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Vitreous-Retina-Macula Consultants of New York
mi
from
New York, NY
Click here to add this to my saved trials